Connor, Clark & Lunn Investment Management Ltd.

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in ALDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$328,641

+$205,057 QoQ

Shares Held

154,292

+546.7% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 108 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. ALDX ranks #83 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$328,641	154,292	+546.7%	Shares	Sole	2026-08-13
2025-12-31	$123,584	23,858	-85.9%	Shares	Sole	2026-02-10
2023-06-30	$1,420,477	169,306	-7.5%	Shares	Sole	2023-08-10
2023-03-31	$1,817,885	183,070	-1.0%	Shares	Sole	2023-05-10
2022-12-31	$1,286,862	184,894	-18.3%	Shares	Sole	2023-02-10
2022-09-30	$1,207,891	226,197	+233.1%	Shares	Sole	2022-11-10
2022-06-30	$270,976	67,914	+315.5%	Shares	Sole	2022-08-05
2020-06-30	$68,162	16,346	-83.6%	Shares	Sole	2020-08-13
2020-03-31	$246,313	99,722	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.